ATYR

3.01

3.61% 0.105

Handel nachbörslich: 2.90 -0.11 -3.65%

Atyr Pharma Inc (ATYR)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$2.905

Offen:

$2.96

24-Stunden-Volumen:

881.46K

Relative Volume:

1.10

Marktkapitalisierung:

$231.18M

Einnahmen:

Nettoeinkommen (Verlust:

KGV:

EPS:

Netto-Cashflow:

1W Leistung:

-10.42%

1M Leistung:

+0.67%

6M Leistung:

+0.00%

1J Leistung:

+0.00%

1-Tages-Spanne:

$2.8501

$3.10

1-Wochen-Bereich:

$2.81

$3.8001

52-Wochen-Spanne:

$1.42

$3.8001

Atyr Pharma Inc Stock (ATYR) Company Profile

Firmenname

Atyr Pharma Inc

Sektor

Healthcare (1196)

Branche

Biotechnology (683)

Telefon

(858) 731-8389

Adresse

10240 SORRENTO VALLEY ROAD, SAN DIEGO

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

ATYR's Discussions on Twitter

Vergleichen Sie ATYR mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ATYR	3.01	231.18M	0	0	0	0.00
VRTX	467.01	119.87B	10.63B	-479.80M	-1.35B	13.33
REGN	762.00	83.27B	13.85B	4.65B	3.32B	35.06
ARGX	567.90	33.96B	1.86B	-40.29M	-1.28B	-4.16
ALNY	232.27	30.18B	2.09B	-332.26M	16.06M	-4.14
BNTX	101.87	24.42B	3.30B	-501.07M	1.03B	11.54

Atyr Pharma Inc Aktie (ATYR) Neueste Nachrichten

Nov 16, 2024

Is aTyr Pharma, Inc. (ATYR) the Best Multibagger Stock to Buy Heading into 2025? - Insider Monkey

Nov 16, 2024

Nov 15, 2024

aTyr Pharma to Present Posters on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis - GlobeNewswire

Nov 15, 2024

aTyr Pharma Stock Soars to 52-Week High of $3.69 Amidst Robust Gains - Investing.com UK

Nov 13, 2024

Nov 10, 2024

aTyr Pharma Third Quarter 2024 Earnings: US$0.23 loss per share (vs US$0.20 loss in 3Q 2023) - Simply Wall St

Nov 10, 2024

Nov 08, 2024

Atyr Pharma: Q3 Earnings Snapshot - Houston Chronicle

Nov 08, 2024

aTyr Pharma Reports Q3 2024 Financial Results - TipRanks

Nov 08, 2024

Nov 07, 2024

aTyr Pharma Inc Reports Q3 Revenue of $0.353 Million, GAAP EPS L - GuruFocus.com

Nov 07, 2024

aTyr Pharma Announces Third Quarter 2024 Results and Provides Corporate Update - GlobeNewswire

Nov 07, 2024

Oct 31, 2024

aTyr Pharma to Present at Upcoming Investor Conferences - GlobeNewswire

Oct 31, 2024

HC Wainwright Reaffirms “Buy” Rating for Atyr PHARMA (NASDAQ:ATYR) - Defense World

Oct 31, 2024

Oct 30, 2024

aTyr Pharma stock soars to 52-week high, hits $3.6 By Investing.com - Investing.com Canada

Oct 30, 2024

aTyr Pharma stock soars to 52-week high, hits $3.6 - Investing.com India

Oct 30, 2024

Oct 29, 2024

aTyr Pharma keeps stock price target with Buy rating by H.C. Wainwright - Investing.com UK

Oct 29, 2024

Atyr PHARMA's (ATYR) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Oct 29, 2024

Oct 28, 2024

Short Interest in Atyr PHARMA INC (NASDAQ:ATYR) Decreases By 21.3% - MarketBeat

Oct 28, 2024

Oct 24, 2024

aTyr Pharma: The Bull Has Finally Come Out (NASDAQ:ATYR) - Seeking Alpha

Oct 24, 2024

High Growth Tech Stocks to Watch in October 2024 - Yahoo Finance

Oct 24, 2024

Oct 21, 2024

Piper Sandler remains bullish on aTyr Pharma, reiterates Overweight rating By Investing.com - Investing.com UK

Oct 21, 2024

Oct 16, 2024

It makes sense and dollars to buy Atyr Pharma Inc (ATYR) stock - SETE News

Oct 16, 2024

Financial Metrics Check: Atyr Pharma Inc (ATYR)’s Ratios for Trailing Twelve Months - The Dwinnex

Oct 16, 2024

Atyr Pharma Inc Inc. (ATYR) Price Performance: The Role of Supply and Demand - The InvestChronicle

Oct 16, 2024

Will ATyr Pharma's Efzofitimod Data In Interstitial Lung Disease Trials Make Waves In 2025? - RTTNews

Oct 16, 2024

Oct 15, 2024

aTyr Pharma stock soars to 52-week high, hits $2.52 - Investing.com India

Oct 15, 2024

aTyr Pharma stock soars to 52-week high, hits $2.52 By Investing.com - Investing.com Australia

Oct 15, 2024